Pathology Grand Rounds - Current WHO and COG Rhabdomyosarcoma Classification and Prognosis

Tuesday, July 15, 2025, 12:00 PM - 1:00 PM PST, Chem-H Neuro E153, Stanford, CA

Pathology Grand Rounds presents the latest research and advancements in various areas of pathology, featuring insights from world-renowned experts. The series incorporates new diagnostic techniques and practice management strategies, emphasizing their utility, limitations, and cost-effectiveness to optimize pathologists' contributions to achieving successful patient outcomes.

Objective(s): 1 Review and discuss genomic medicine topics in pathology to enhance competence and quality of patient care. 2 Apply new genomic assays in the diagnosis and classification of cancer. 3 Integrate advances in digital pathology into clinical practice. 4 Review and discuss current peer-reviewed pathology articles to enhance competence and patient care quality.
Location: Alway Building
Specialties: Pathology & Laboratory Medicine

Faculty Disclosures:
Michael A Arnold, MD, PhD (Nothing to disclose - 05/07/2025)
Download Handout

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)

1. Review and discuss genomic medicine topics in pathology to enhance competence and quality of patient care.
2. Apply new genomic assays in the diagnosis and classification of cancer.
3. Integrate advances in digital pathology into clinical practice.
4. Review and discuss current peer-reviewed pathology articles to enhance competence and patient care quality.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
     Name: Annie Vo 
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Date	Empty Column	Title
7/15/2025 12:00:00 PM	Pathology Grand Rounds - Current WHO and COG Rhabdomyosarcoma Classification and Prognosis 7/15/2025 12:00:00 PM 7/15/2025 1:00:00 PM 6 Chem-H Neuro E153 False MM/DD/YYYY	Pathology Grand Rounds - Current WHO and COG Rhabdomyosarcoma Classification and Prognosis Pathology Grand Rounds presents the latest research and advancements in various areas of pathology, featuring insights from world-renowned experts. The series incorporates new diagnostic techniques and practice management strategies, emphasizing their utility, limitations, and cost-effectiveness to optimize pathologists' contributions to achieving successful patient outcomes. Objective(s): 1 Review and discuss genomic medicine topics in pathology to enhance competence and quality of patient care. 2 Apply new genomic assays in the diagnosis and classification of cancer. 3 Integrate advances in digital pathology into clinical practice. 4 Review and discuss current peer-reviewed pathology articles to enhance competence and patient care quality. Location: Alway Building Specialties: Pathology & Laboratory Medicine Faculty Disclosures: Michael A Arnold, MD, PhD (Nothing to disclose - 05/07/2025) Download Handout Location: Chem-H Neuro E153 Specialties: Pathology & Laboratory Medicine